Aldesleukin User Reviews & Ratings
Brand names: Proleukin
Aldesleukin has an average rating of 10.0 out of 10 from a total of 1 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Renal Cell Carcinoma | 1 reviews for Renal Cell Carcinoma | 23 medications |
See also:
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Lenvima
Lenvima (lenvatinib) is used to treat thyroid cancer, advanced renal cell carcinoma, hepatocellular ...
Cabometyx
Cabometyx is used to treat advanced kidney cancer, liver cancer, thyroid cancer, and pancreatic and ...
Afinitor
Afinitor prevents the growth of cancer cells and is used to treat advanced kidney cancer. Learn ...
Lenvatinib
Lenvatinib is used to treat thyroid cancer, kidney cancer, liver cancer, and advanced endometrial ...
Everolimus
Everolimus (Afinitor, Afinitor Disperz, Zortress) belongs to a class of drugs called kinase ...
Are you taking this medicine?
Your review helps others make informed decisions.More about aldesleukin
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: interleukins
- En español
For Renal Cell Carcinoma "I was diagnosed with Stage IV renal cell carcinoma (RCC) in April 2009, and told by my primary care physician that my prognosis was approximately 6-9 months, perhaps a year. I found an oncologist that specialized in RCC and was told that this was the only course of action that had the potential to cure, not just stall the progression of my cancer. After 3 courses, I have had a complete response - no detectable cancer for 6 months so far."